FI3867247T3 - Uusia yhdisteitä - Google Patents

Uusia yhdisteitä Download PDF

Info

Publication number
FI3867247T3
FI3867247T3 FIEP19790048.3T FI19790048T FI3867247T3 FI 3867247 T3 FI3867247 T3 FI 3867247T3 FI 19790048 T FI19790048 T FI 19790048T FI 3867247 T3 FI3867247 T3 FI 3867247T3
Authority
FI
Finland
Prior art keywords
yyli
dioni
etyyli
syklopropan
bentsofuraani
Prior art date
Application number
FIEP19790048.3T
Other languages
English (en)
Finnish (fi)
Inventor
Giuseppe Alvaro
Agostino Marasco
Original Assignee
Autifony Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Autifony Therapeutics Ltd filed Critical Autifony Therapeutics Ltd
Application granted granted Critical
Publication of FI3867247T3 publication Critical patent/FI3867247T3/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FIEP19790048.3T 2018-10-16 2019-10-16 Uusia yhdisteitä FI3867247T3 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18200626 2018-10-16
PCT/GB2019/052937 WO2020079422A1 (en) 2018-10-16 2019-10-16 Novel compounds

Publications (1)

Publication Number Publication Date
FI3867247T3 true FI3867247T3 (fi) 2024-10-30

Family

ID=63878368

Family Applications (1)

Application Number Title Priority Date Filing Date
FIEP19790048.3T FI3867247T3 (fi) 2018-10-16 2019-10-16 Uusia yhdisteitä

Country Status (21)

Country Link
US (1) US20250304564A1 (cg-RX-API-DMAC7.html)
EP (1) EP3867247B1 (cg-RX-API-DMAC7.html)
JP (1) JP7465868B2 (cg-RX-API-DMAC7.html)
KR (1) KR102854594B1 (cg-RX-API-DMAC7.html)
AR (1) AR116713A1 (cg-RX-API-DMAC7.html)
AU (1) AU2019360017B9 (cg-RX-API-DMAC7.html)
BR (1) BR112021006940A2 (cg-RX-API-DMAC7.html)
DK (1) DK3867247T3 (cg-RX-API-DMAC7.html)
ES (1) ES2988842T3 (cg-RX-API-DMAC7.html)
FI (1) FI3867247T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20241318T1 (cg-RX-API-DMAC7.html)
HU (1) HUE068686T2 (cg-RX-API-DMAC7.html)
IL (1) IL282096B2 (cg-RX-API-DMAC7.html)
LT (1) LT3867247T (cg-RX-API-DMAC7.html)
MX (1) MX2021004386A (cg-RX-API-DMAC7.html)
PL (1) PL3867247T3 (cg-RX-API-DMAC7.html)
PT (1) PT3867247T (cg-RX-API-DMAC7.html)
SI (1) SI3867247T1 (cg-RX-API-DMAC7.html)
TW (1) TWI827706B (cg-RX-API-DMAC7.html)
WO (1) WO2020079422A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202101487B (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12358901B2 (en) 2018-10-16 2025-07-15 Autifony Therapeutics Limited KV3 modulators
BR112022013339A2 (pt) * 2020-02-06 2022-09-13 Autifony Therapeutics Ltd Moduladores de kv3
EP4384165B1 (en) * 2021-08-09 2025-07-09 Janssen Pharmaceutica NV Monoacylglycerol lipase modulators for use in autism spectrum disorders
CA3226856A1 (en) 2021-08-10 2023-02-16 Autifony Therapeutics Limited Potassium channel modulators
EP4630117A1 (en) 2022-12-06 2025-10-15 Autifony Therapeutics Limited Compounds for the treatment of centra nervous system disorders
WO2026093398A1 (en) 2024-10-29 2026-05-07 Autifony Therapeutics Limited Kv3 modulators for use in the treatment or prophylaxis of amyotrophic lateral sclerosis (als)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2509961B1 (en) 2009-12-11 2016-03-09 Autifony Therapeutics Limited Imidazolidinedione derivatives
KR101862375B1 (ko) 2010-12-06 2018-05-29 오티포니 세라피틱스 리미티드 Kv3 억제제로서 유용한 하이단토인 유도체
US9193704B2 (en) 2011-06-07 2015-11-24 Autifony Therapeutics Limited Hydantoin derivatives as KV3 inhibitors
GB201209986D0 (en) 2012-06-06 2012-07-18 Autifony Therapeutics Ltd Novel compounds
PL2788339T3 (pl) 2011-12-06 2016-09-30 Pochodne hydantoiny przydatne jako inhibitory KV3
CN104334547B (zh) 2012-05-22 2017-06-06 奥蒂福尼疗法有限公司 作为kv3抑制剂的三唑类
JP2015517563A (ja) 2012-05-22 2015-06-22 アウトイフオンイ トヘラペウトイクス リミテッド Kv3阻害剤としてのヒダントイン誘導体
WO2013182851A1 (en) 2012-06-06 2013-12-12 Autifony Therapeutics Limited Prophylaxis or treatment of diseases where a modulator of kv3.3 channels is required
GB201521751D0 (en) 2015-12-10 2016-01-27 Autifony Therapeutics Ltd Novel uses
GB201522179D0 (en) 2015-12-16 2016-01-27 Autifony Therapeutics Ltd Novel compounds
GB201613163D0 (en) 2016-07-29 2016-09-14 Autifony Therapeutics Ltd Novel compounds
US20200039970A1 (en) 2016-12-16 2020-02-06 Autifony Therapeutics Limited Hydantoin modulators of kv3 channels

Also Published As

Publication number Publication date
SI3867247T1 (sl) 2024-11-29
TWI827706B (zh) 2024-01-01
ES2988842T3 (es) 2024-11-21
HUE068686T2 (hu) 2025-01-28
JP2022505143A (ja) 2022-01-14
TW202035394A (zh) 2020-10-01
WO2020079422A1 (en) 2020-04-23
AU2019360017B2 (en) 2025-03-06
DK3867247T3 (da) 2024-09-16
IL282096A (en) 2021-05-31
KR20210076081A (ko) 2021-06-23
IL282096B1 (en) 2024-03-01
EP3867247A1 (en) 2021-08-25
MX2021004386A (es) 2021-06-04
PL3867247T3 (pl) 2024-12-09
PT3867247T (pt) 2024-09-17
HRP20241318T1 (hr) 2024-12-20
AR116713A1 (es) 2021-06-02
AU2019360017A1 (en) 2021-04-01
EP3867247B1 (en) 2024-07-24
LT3867247T (lt) 2024-11-11
BR112021006940A2 (pt) 2021-07-13
JP7465868B2 (ja) 2024-04-11
AU2019360017B9 (en) 2025-03-27
KR102854594B1 (ko) 2025-09-02
US20250304564A1 (en) 2025-10-02
IL282096B2 (en) 2024-07-01
ZA202101487B (en) 2024-05-30

Similar Documents

Publication Publication Date Title
SA519402462B1 (ar) مشتقات بيرولو[1، 2-b]بيريدازين
IL288236A (en) 3,2-dihydroquinazoline compounds as inhibitors of nav1.8
FI3704120T3 (fi) Heterosyklisiä yhdisteitä prmt5:n estäjinä
EP4037688A4 (en) ANTIVIRAL HETEROCYCLIC COMPOUNDS
SI3625233T1 (sl) Derivati 3-(((((2S,5R)-2-karbamoil-7-okso-1,6-diazabiciklo(3.2.1)oktan-6-IL)oksi) sulfonil)oksi)-2.2-dimetilpropanoat in povezane spojine kot peroralno dana predzdravila zaviralcev beta-laktamaze za zdravljenje bakterijskih okužb
MA55751A (fr) Composés de 4h-pyrrolo[3,2-c]pyridin-4-one
EP2657233A4 (en) 3,5-DISUBSTITUTED ALKYNYL BENZEN COMPOUND AND SALT THEREFOR
WO2008116064A3 (en) Fused heterocyclic compounds useful for the treatment of proliferative, allergic, autoimmune or inflammatory diseases
EP4028401C0 (en) 4,4A,5,7,8,8A-HEXAPYRIDO[4,3-B][1,4]OXAZIN-3-ONE COMPOUNDS AS MAGL INHIBITORS
MX2017011579A (es) Pesticidas de tipo azol bicíclicos sustituidos con un heterociclo.
EP4241387A4 (en) PROCEDURE FOR PMI, RI AND PORT INDEXING CSI FOR MULTIPLE TRANSCEIVER POINTS
WO2009027971A3 (en) Antimicrobial polymers
EP3564238A4 (en) CONDENSED HETEROCYCLIC COMPOUND WITH OXIMUM GROUP OR SALTS THEREOF, INSECTICIDE FOR AGRICULTURE / GARDENING WITH THE COMPOSITE AND METHOD FOR USING THE INSECTICIDE
WO2014159738A3 (en) Solid forms of 5-(halomethyl) furfural
EP4028399C0 (en) ANTIBACTERIAL COMPOUNDS
MA53432A (fr) Imidazo[1,2-b]pyridazines utilisées en tant qu'inhibiteurs de trk
DK3402781T5 (da) 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4,5]-decan-derivater
MY182812A (en) Tricyclic compound and jak inhibitor
EP3922631A4 (en) 5-(4-PYRIDYLOXY)PYRAZOLE COMPOUNDS AS A TGF-BETA R1 KINASE INHIBITOR
MA53165A (fr) Dérivés d'imidazo[1,2-b]pyridazine utilisés en tant qu'inhibiteurs de trk
MX2022008470A (es) Compuesto antibacteriano de cefalosporina y aplicacion farmaceutica del mismo.
WO2018075454A8 (en) Functional surfaces
EP4472979A4 (en) 1H-PYRAZOLO[4,3-D]PYRIMIDINE DERIVATIVES USED AS STAPHYLOCOCCUS AUREUS INHIBITORS
EP4005637A4 (en) HETEROCYCLIC COMPOUND
GB201903077D0 (en) Automated intelligent node for hybrid fiber-coaxial (HFC) networks